A device made by Santa Barbara-based Active Life Scientific played a critical role in a new study at the Mayo Clinic linking Type 2 diabetes to bone problems.
By Tom Bronzini / Wednesday, November 7th, 2012 / Latest news, Technology / Comments Off on Amgen deals could foster biotech hub, panel says
Amgen’s decision to license some of its intellectual property to a new drug company that will operate near the biotechnical giant’s Thousand Oaks headquarters could be an exciting development for biotech firms in the 101 corridor, business leaders were told at a breakfast gathering Wednesday in Westlake Village. The move could be a start toward Read More →